Literature DB >> 984744

Antimicrobial susceptibility of group B streptococci isolated from a variety of clinical sources.

C J Baker, B J Webb, F F Barrett.   

Abstract

The minimal inhibitory concentration of 10 antibiotics for 244 isolates of group B streptococci was determined. Susceptibility to penicillin G, ampicillin, cephalothin, chloramphenicol, and carbenicillin was uniform. Tetracycline and bacitracin resistance among these isolates was frequent (87.5 and 97.9%, respectively). Three strains (1.2%) failed to be inhibited by 100 mug of lincomycin or clindamycin per ml. Susceptibility of these 244 strains to the agents tested was unrelated to source of the isolate, year of isolation, or strain serotype. No apparent change in the suceptibility of group B streptococci to penicillin G has occurred during the past 2 decades.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 984744      PMCID: PMC429701          DOI: 10.1128/AAC.10.1.128

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Group B streptococcus in a general hospital.

Authors:  B F Anthony; N F Concepcion
Journal:  J Infect Dis       Date:  1975-11       Impact factor: 5.226

2.  Susceptibility of various serogroups of streptococci to clindamycin and lincomycin.

Authors:  A W Karchmer; R C Moellering; B K Watson
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

3.  NEONATAL SEPSIS AND OTHER INFECTIONS DUE TO GROUP B BETA-HEMOLYTIC STREPTOCOCCI.

Authors:  T C EICKHOFF; J O KLEIN; A K DALY; D INGALL; M FINLAND
Journal:  N Engl J Med       Date:  1964-12-10       Impact factor: 91.245

4.  Susceptibility of hemolytic streptococci, other than those of group D, to eleven antibiotics in vitro.

Authors:  W F JONES; H A FELDMAN; M FINLAND
Journal:  Am J Clin Pathol       Date:  1957-02       Impact factor: 2.493

5.  Resistance of group A beta-hemolytic streptococci to lincomycin and erythromycin.

Authors:  J M Dixon; A E Lipinski
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

6.  The spectrum of group B streptococcal infections in infancy.

Authors:  J B Howard; G H McCracken
Journal:  Am J Dis Child       Date:  1974-12

7.  Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants.

Authors:  C J Baker; F F Barrett; R C Gordon; M D Yow
Journal:  J Pediatr       Date:  1973-04       Impact factor: 4.406

8.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

9.  A comparison of early-onset group B steptococcal neonatal infection and the respiratory-distress syndrome of the newborn.

Authors:  R C Ablow; S G Driscoll; E L Effmann; I Gross; C J Jolles; R Uauy; J B Warshaw
Journal:  N Engl J Med       Date:  1976-01-08       Impact factor: 91.245

10.  Observations and comments concerning the isolation of group B beta-hemolytic streptococci from human sources.

Authors:  P D Finn; F A Holden
Journal:  Can Med Assoc J       Date:  1970-08-01       Impact factor: 8.262

  10 in total
  20 in total

1.  High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan.

Authors:  P R Hsueh; L J Teng; L N Lee; S W Ho; P C Yang; K T Luh
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

2.  Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis.

Authors:  M Fernandez; M E Hickman; C J Baker
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

3.  Colonization rates and serotypes of group B streptococci isolated from pregnant women in a Korean tertiary hospital.

Authors:  Y Uh; I H Jang; K J Yoon; C H Lee; J Y Kwon; M C Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-10       Impact factor: 3.267

4.  Active efflux of antimicrobial agents in wild-type strains of enterococci.

Authors:  C Lynch; P Courvalin; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

5.  Antimicrobial susceptibility of group B streptococci.

Authors:  K M Persson; A Forsgren
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

Review 6.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Antibiotic resistance patterns of group B streptococci in pregnant women.

Authors:  K Berkowitz; J A Regan; E Greenberg
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

8.  Serotypes and genotypes of erythromycin-resistant group B streptococci in Korea.

Authors:  Young Uh; In Ho Jang; Gyu Yel Hwang; Mi Kyung Lee; Kap Jun Yoon; Hyo Youl Kim
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

9.  Streptococcus agalactiae (group B) endocarditis--a description of twelve cases and review of the literature.

Authors:  B E Scully; D Spriggs; H C Neu
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

10.  Comparative in vitro bactericidal activity of cefonicid, ceftizoxime, and penicillin against group B streptococci.

Authors:  A S Bayer; J O Morrison; K S Kim
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.